TABLE 2.
Pharmacokinetic model-building summary for L-AmB
| Model no. | Modela | Compared against | OFV | ΔOFV | SIG (P)b |
|---|---|---|---|---|---|
| One compartment | |||||
| 1 | CL = θ1 · EXP(η) | 1,158.2 | |||
| V = θ2 · EXP(η) | |||||
| 2 | CL = θ1 · EXP(η + κ) | 1 | 1,102.6 | −55.6 | <0.001 |
| V = θ2 · EXP(η + κ) | |||||
| Two compartment | |||||
| 3 | CL = θ1 · EXP(η) | 484.40 | |||
| V1 = θ2 · EXP(η) | |||||
| 4 | CL = θ1 · EXP(η + κ) | 3 | 398.94 | −85.5 | <0.001 |
| V1 = θ2 · EXP(η + κ) | |||||
| 5 | CL = θ1 · EXP(θ5 · (WT − 21)) · EXP(η + κ) | 4 | 394.63 | −4.31 | <0.05 |
| V1 = θ2 · EXP(η + κ) | |||||
| 6 | CL = θ1 · EXP(θ5 · (age − 6.5)) · EXP(η + κ) | 4 | 396.20 | −2.74 | |
| V1 = θ2 · EXP(η + κ) | |||||
| 7 | CL = θ1 · EXP(η + κ) | 4 | 394.74 | −4.20 | <0.05 |
| V1 = θ2 · EXP(θ5 · (WT − 21)) · EXP(η + κ) | |||||
| 8 | CL = θ1 · EXP(η + κ) | 4 | 395.04 | −3.90 | <0.05 |
| V1 = θ2 · EXP(θ5 · (age − 6.5)) · EXP(η + κ) | |||||
| 9 | CL = θ1 · EXP(θ5 · (WT − 21)) · EXP(η + κ) | 5 | 380.93 | −13.7 | <0.001 |
| V1 = θ2 · EXP(θ6 · (WT − 21)) · EXP(η + κ) | |||||
| 10 | CL = θ1 · EXP(θ5 · (WT − 21)) · EXP(η + κ) | 9 | 382.10 | 1.16 | |
| V1 = θ2 · EXP(θ6 · (WT − 21)) · EXP(θ7 · (age − 6.5)) · EXP(η + κ) |
η, random variable of interindividual variability; κ, random variable of between occasion variability. WT is centered to the cohort median value of 21 kg; age is centered to the cohort median value of 6.5 years.
SIG, Significance of adding covariates into a model, assessed by P value.